Clinical Trials Browser

Interventional × Advanced Cancer × tislelizumab × Clear all

NCT02407990 2021-11-17

Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors

Phase 1 Completed

451 enrolled 42 charts

Advanced Cancer